Long Focus Capital Management, LLC Standard Biotools Inc. Transaction History
Long Focus Capital Management, LLC
- $2.69 Billion
- Q3 2025
A detailed history of Long Focus Capital Management, LLC transactions in Standard Biotools Inc. stock. As of the latest transaction made, Long Focus Capital Management, LLC holds 11,362,804 shares of LAB stock, worth $14.1 Million. This represents 0.55% of its overall portfolio holdings.
Number of Shares
11,362,804
Previous 10,070,000
12.84%
Holding current value
$14.1 Million
Previous $12.1 Million
22.24%
% of portfolio
0.55%
Previous 0.56%
Shares
3 transactions
Others Institutions Holding LAB
# of Institutions
163Shares Held
284MCall Options Held
59.7KPut Options Held
18.7K-
Casdin Capital, LLC New York, NY77.6MShares$96.2 Million13.74% of portfolio
-
Viking Global Investors LP58.7MShares$72.7 Million0.22% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$27 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.2MShares$21.4 Million0.0% of portfolio
-
Mak Capital One LLC New York, NY15.9MShares$19.8 Million3.18% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $97.5M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...